Screening of malignant neoplasms: the state of the problem in Russia and the world
https://doi.org/10.31146/1682-8658-ecg-211-3-5-16
Abstract
A number of objective and subjective reasons, such as aging of the population, environmental, economic and other factors, determine the trend of increasing incidence of malignant neoplasms worldwide. According to GLOBOCAN 2020 forecasts, in the coming years, prostate, lung and bronchial cancer, colorectal cancer will account for almost half (48%) of all cases of the disease in men, of which 27% are prostate cancer. In women, breast cancer, lung cancer and colorectal cancer will account for about 51% of all new diagnoses, while breast cancer alone will account for about 30%. In 2021, the Ministry of Health of the Russian Federation approved the Procedure for preventive examinations and medical examinations, within the framework of which screening measures for early detection of oncological diseases are carried out, the procedure for dispensary observation of certain groups of the adult population by specialist doctors is approved, the duration, frequency of dispensary observation, the scope of preventive, diagnostic, therapeutic and rehabilitation measures are determined. The aim of the review: to present epidemiological data on the most common forms of cancer in Russia and the world; current recommendations on the organization of screening and its informative value; primary prevention measures.
About the Authors
M. A. Livzan
Omsk State Medical University
Russian Federation
Russian Federation
E. A. Lyalyukova
Omsk State Medical University
Russian Federation
Russian Federation
V. Yu. Petrosian
West Siberian Medical Center of Federal Biomedical Agency
Russian Federation
Russian Federation
E. N. Chernysheva
Astrakhan State Medical University
Russian Federation
Russian Federation
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660.
2. Yabroff KR, Wu XC, Negoita S, Stevens J, Coyle L, Zhao J, Mumphrey BJ, Jemal A, Ward KC. Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services. J Natl Cancer Inst. 2022 Jun 13;114(6):907-909. doi: 10.1093/jnci/djab122.
3. Kaprin A.D., Starinsky V. V., Shakhzadova A. O. [The state of oncological care for the population of Russia in 2021]. Moscow. MNIOI im. P. A. Herzen - branch of the Federal State Budgetary Institution “NMITs Radiology” of the Ministry of Health of Russia Publ., 2022, 239 P. (in Russ.) ISBN 978-5-85502-275-9.@@ Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой Состояние онкологической помощи населению России в 2021 году. - М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. - илл. - 239 с. ISBN 978-5-85502-275-9.
4. [On approval of the Procedure for conducting a preventive medical examination and medical examination of certain groups of the adult population]. Order of the Ministry of Health of Russia (Ministry of Health of the Russian Federation) dated April 27, 2021 No. 404n. (in Russ.)@@ Приказ Минздрава России (Министерство здравоохранения РФ) от 27 апреля 2021 г. № 404н «Об утверждении Порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения»
5. [On approval of the procedure for dispensary observation of adults]. Order of the Ministry of Health of Russia dated March 15, 2022 n 168n. (in Russ.)@@ Приказ Минздрава России от 15 марта 2022 г. n 168н «Об утверждении порядка проведения диспансерного наблюдения за взрослыми»
6. Smith R.A., Andrews K. S., Brooks D. et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018 Jul;68(4):297-316. doi: 10.3322/caac.21446.
7. [Malignant neoplasm of the bronchi and lung]. Clinical recommendations of the Ministry of Health of the Russian Federation protocol dated December 25, 2020 No 17-4 / 4884. 2021. (in Russ.)@@ Злокачественное новообразование бронхов и легкого. Клинические рекомендации МЗ РФ протокол от 25.12.2020 No 17-4/4884. 2021.
8. Office of the Surgeon General (US); Office on Smoking and Health (US). The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2004. PMID: 20669512.
9. Bade B.C., Dela Cruz C. S. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001.
10. [Cancer of the cervix]. Clinical recommendations of the Ministry of Health of the Russian. dec 20 2019. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак шейки матки. 2020
11. Simms K.T., Steinberg J., Caruana M., et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2.
12. Howlader N., Noone A. M., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017.
13. Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020 Feb;8(2): e191-e203. doi: 10.1016/S2214-109X(19)30482-6.
14. Morgan E., Arnold M., Camargo M. C. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404.
15. [Stomach cancer]. Clinical recommendations of the Ministry of Health of the Russian. 2020. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак желудка (2021).
16. van der Post R. S., Vogelaar I. P., Carneiro F. et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015 Jun;52(6):361-74. doi: 10.1136/jmedgenet-2015-103094.
17. Petrovchich I, Ford JM. Genetic predisposition to gastric cancer. Semin Oncol. 2016 Oct;43(5):554-559. doi: 10.1053/j.seminoncol.2016.08.006.
18. Poddubnaya I.V., Kaprin A. D., Lyadov V. K. Classification of TNM tumors. 8th ed. Guide and atlas. T. I: Tumors of thoracoabdominal localization. Moscow. Practical medicine, 2018, 424 p. (in Russ.)@@ Поддубная И. В., Каприн А. Д., Лядов В. К. Классификация опухолей TNM. 8-я ред. Руководство и атлас. Т. I: Опухоли торакоабдоминальной локализации. М.; Практическая медицина, 2018. - 424 с.
19. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27(suppl 5): v38-v49. doi: 10.1093/annonc/mdw350.
20. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Gastric Cancer Version 2.2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (accessed on July 7, 2019).
21. Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492.
22. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Guilherme M, Barbosa J, Lomba-Viana H, Silva R, Moreira-Dias L. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004 Feb;57(2):177-82. doi: 10.1136/jcp.2003.11270.
23. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacterand Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
24. Ivashkin V. T., Maev I. V., Lapina T. L. et al. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(4):70-99. (In Russ.) doi: 10.22416/1382-4376-2021-31-4-70-99.@@ Ивашкин В. Т., Маев И. В., Лапина Т. Л. и соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации «Эндоскопическое общество РЭНДО» по диагностике и лечению гастрита, дуоденита. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(4):70-99. doi: 10.22416/1382-4376-2021-31-4-70-99.
25. Malfertheiner P., Megraud F., Rokkas T., Gisbert J. P., Liou J. M., Schulz C., Gasbarrini A., Hunt R. H., Leja M., O’Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M.; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022 Aug 8: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.
26. Bordin D.S., Livzan M. A. Maastricht VI consensus published: what’s new? Effective pharmacotherapy. 2022; 18(22): 72-84. (in Russ.) doi: 10.33978/2307-3586-2022-18-22-72-84.@@ Бордин Д. С., Ливзан М. А. Консенсус Маастрихт VI опубликован: что нового? Эффективная фармакотерапия. 2022; 18 (22): 72-84. doi: 10.33978/2307-3586-2022-18-22-72-84
27. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736.
28. Starostin R.A., Gataullin B. I., Valitov B. R., Gataullin I. G. Colorectal cancer: epidemiology and risk factors. Povolzhsky Oncological Bulletin. 2021;4 (48). (in Russ.) (Available at: https://cyberleninka.ru/article/n/kolorektalnyy-rak-epidemiologiya-i-faktory-riska Access: 01.03.2023)@@ Старостин Р. А., Гатауллин Б. И., Валитов Б. Р., Гатауллин И. Г. Колоректальный рак: эпидемиология и факторы риска. Поволжский онкологический вестник. 2021. № 4 (48). URL: https://cyberleninka.ru/article/n/kolorektalnyy-rak-epidemiologiya-i-faktory-riska (дата обращения: 01.03.2023).
29. Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: An Evidence Update for the U. S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-1. PMID: 34097369.
30. van Leerdam M. E., Roos V. H., van Hooft J. E. et al. Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019 Sep;51(9):877-895. doi: 10.1055/a-0965-0605.
31. Song M., Garrett W. S., Chan A. T. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015 May;148(6):1244-60.e16. doi: 10.1053/j.gastro.2014.12.035.
32. Magalhães B., Peleteiro B., Lunet N. Dietary patterns and colorectal cancer: systematic review and meta-analysis. Eur J Cancer Prev. 2012 Jan;21(1):15-23. doi: 10.1097/CEJ.0b013e3283472241.
33. Arem H., Moore S. C., Park Y., Ballard-Barbash R., Hollenbeck A., Leitzmann M., Matthews C. E. Physical activity and cancer-specific mortality in the NIH-AARP Diet and Health Study cohort.Int J Cancer. 2014 Jul 15; 135(2):423-31. doi: 10.1002/ijc.28659.
34. Algra A.M., Rothwell P. M. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012 May;13(5):518-27. doi: 10.1016/S1470-2045(12)70112-2.
35. World Gastroenterology Organisation, Practice Guideline - Colorectal cancer screening, 2008.
36. Lieberman D. A. Clinical practice. Screening for colorectal cancer. N. Engl. J. Med. 2009; 361(12): 1179-1187. doi: 10.1056/NEJMcp0902176.
37. Laine L. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest. Endosc. 2015; 148(3): 639-651.e28. doi: 10.1053/j.gastro.2015.01.031.
38. Magro F. et al. Third European evidence-based consensus on diagnosis and man. agement of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal mani-festations, pregnancy, cancer surveillance, surgery, and Ileo-anal pouch disorders J. Crohns Colitis. 2017; 11(6): 649-670. doi: 10.1093/ecco-jcc/jjx008.
39. Grossman D.C., Curry S. J., Owens D. K. et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
40. Stanford J.L., Stephenson R. A., Coyle L. M. et al. Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute, NIH Pub.; 99-4543, Bethesda: MD; 1999.
41. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17(4):337-47. doi: 10.1002/pros.2990170409.
42. Tan D.S., Mok T. S., Rebbeck T. R. Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. J Clin Oncol. 2016 Jan 1;34(1):91-101. doi: 10.1200/JCO.2015.62.0096.
43. Denis L., Morton M. S., Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol. 1999;35(5-6):377-87. doi: 10.1159/000019912.
44. Catalona W. J. Prostate Cancer Screening. Med Clin North Am. 2018 Mar;102(2):199-214. doi: 10.1016/j.mcna.2017.11.001.
45. Thompson I.M., Ankerst D. P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131.
46. [Prostate Cancer]. Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (in Russ.)@@ Клинические рекомендации МЗ РФ. Рак предстательной железы (2021).
47. Lippi G., Mattiuzzi C. Fried food and prostate cancer risk: systematic review and meta-analysis.Int J Food Sci Nutr. 2015;66(5):587-9. doi: 10.3109/09637486.2015.1056111.
48. DeSantis C.E., Bray F., Ferlay J., Lortet-Tieulent J., Anderson B. O., Jemal A.International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506. doi: 10.1158/1055-9965.EPI-15-0535.
49. Ginsburg O., Yip C. H., Brooks A. et al. Breast cancer early detection: A phased approach to implementation. Cancer. 2020 May 15;126 Suppl 10(Suppl 10):2379-2393. doi: 10.1002/cncr.32887.
50. Vysotskaya I. V. Endocrine-sensitive tumors of the reproductive system: a guide for physicians. Moscow. Spec. publishing house med. book. (SIMC). 2014. 126 p. (in Russ.)@@ Высоцкая И. В. Эндокринно-чувствительные опухоли репродуктивной системы: руководство для врачей. М.: Спец. изд-во мед. кн. (СИМК). 2014. 126 с.
51. [Mammary cancer]. Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (in Russ.)@@ Клинические рекомендации. Рак молочной железы, 2021
52. Fidler M.M., Gupta S., Soerjomataram I., Ferlay J., Steliarova-Foucher E., Bray F. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017 Dec;18(12):1579-1589. doi: 10.1016/S1470-2045(17)30677-0.
Review
For citations:
Livzan M.A., Lyalyukova E.A., Petrosian V.Yu., Chernysheva E.N. Screening of malignant neoplasms: the state of the problem in Russia and the world. Experimental and Clinical Gastroenterology. 2023;(3):5-16. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-211-3-5-16
Views:
346
Email this article 